Requip and Escitalopram drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Requip and Escitalopram. Common interactions include dyspnoea exertional among females and klebsiella sepsis among males.
The phase IV clinical study analyzes what interactions people who take Requip and Escitalopram have. It is created by eHealthMe based on reports of 141 people who take Requip and Escitalopram from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
141 people who take Requip and Escitalopram together, and have interactions are studied.
What is Requip?
Requip has active ingredients of ropinirole hydrochloride. It is often used in restless leg syndrome. eHealthMe is studying from 22,097 Requip users for its effectiveness, alternative drugs and more.
What is Escitalopram?
Escitalopram has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 62,511 Escitalopram users for its effectiveness, alternative drugs and more.
Number of Requip and Escitalopram reports submitted per year:
Requip and Escitalopram drug interactions by gender *:
Requip and Escitalopram drug interactions by age *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Requip and Escitalopram?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
Related studies
Alternative drugs to, pros and cons of the 2 drugs:
- Requip (22,097 reports)
- Escitalopram (62,511 reports)
Common Requip and Escitalopram interactions:
- Migraine (headache): 5 reports
Browse all drug interactions of Requip and Escitalopram:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Requip side effects:
- Drug ineffective: 1,870 reports
- Fatigue (feeling of tiredness): 1,331 reports
- Drowsiness: 1,164 reports
- Dizziness: 1,134 reports
- Pain: 1,043 reports
Browse all side effects of Requip:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Escitalopram side effects:
- Fatigue (feeling of tiredness): 4,064 reports
- Drug ineffective: 3,486 reports
- Diarrhea: 2,974 reports
- Dizziness: 2,937 reports
- Stress and anxiety: 2,901 reports
- Headache (pain in head): 2,848 reports
- Weakness: 2,535 reports
Browse all side effects of Escitalopram:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Requip interactions:
- Requip and Aspirin: 2,449 reports
- Requip and Sinemet: 1,967 reports
- Requip and Gabapentin: 1,668 reports
- Requip and Lasix: 1,564 reports
- Requip and Lyrica: 1,561 reports
- Requip and Lisinopril: 1,558 reports
- Requip and Synthroid: 1,505 reports
- Requip and Cymbalta: 1,494 reports
- Requip and Lipitor: 1,409 reports
- Requip and Neurontin: 1,258 reports
Browse all interactions between Requip and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Escitalopram interactions:
- Escitalopram and Gabapentin: 5,399 reports
- Escitalopram and Aspirin: 5,184 reports
- Escitalopram and Pantoprazole: 5,101 reports
- Escitalopram and Omeprazole: 5,036 reports
- Escitalopram and Prednisone: 4,043 reports
- Escitalopram and Amlodipine: 3,990 reports
- Escitalopram and Alprazolam: 3,868 reports
- Escitalopram and Furosemide: 3,858 reports
- Escitalopram and Loraz: 3,852 reports
- Escitalopram and Vitamin d: 3,673 reports
Browse all interactions between Escitalopram and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on ropinirole hydrochloride and escitalopram oxalate (the active ingredients of Requip and Escitalopram, respectively), and Requip and Escitalopram (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Requip and Escitalopram.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Opdivo and Fentanyl Citrate drug interaction - now
- Carafate and Type 1 Diabetes - 4 seconds ago
- Carafate and Synagis drug interaction - 6 seconds ago
- Norvasc and Post-Operative Wound Breakdown - 16 seconds ago
- Zyprexa and Salivary Hypersecretion - 17 seconds ago
- Neupogen and Bladder Disorder - 24 seconds ago
- Betaxolol Hydrochloride and Gliclazide drug interaction - 31 seconds ago
- Cytosar-U and Methotrexate drug interaction - 36 seconds ago
- Tamiflu and Breast Infection - 38 seconds ago
- Vitamin B12 Decreased and Itching - 47 seconds ago